Placebo test
| Variables | Model 1 | Model 2 |
|---|---|---|
| Commit | Inno | |
| DID | 0.048 | −0.042 |
| (0.043) | (0.035) | |
| Age | 0.044*** | −0.026*** |
| (0.006) | (0.004) | |
| Size | 0.033 | 0.061*** |
| (0.024) | (0.020) | |
| ROA | −0.012 | 0.101 |
| (0.125) | (0.102) | |
| Leverage | −0.097 | −0.086 |
| (0.074) | (0.068) | |
| Tb_Q | −0.001 | −0.012*** |
| (0.006) | (0.004) | |
| SOE | −0.040 | 0.104* |
| (0.060) | (0.054) | |
| Independ_Director | −0.003 | −0.126 |
| (0.242) | (0.233) | |
| Largest_Share | 0.026 | −0.129 |
| (0.160) | (0.114) | |
| Chairman_Duality | −0.052* | 0.010 |
| (0.030) | (0.025) | |
| Board_Size | −0.003 | 0.009 |
| (0.011) | (0.010) | |
| Constant | −0.597 | −0.703 |
| (0.539) | (0.429) | |
| Observations | 8,822 | 9,218 |
| Firm FE | Yes | Yes |
| Year FE | Yes | Yes |
| R-squared | 0.070 | 0.073 |
| Variables | Model 1 | Model 2 |
|---|---|---|
| Commit | Inno | |
| 0.048 | −0.042 | |
| (0.043) | (0.035) | |
| 0.044*** | −0.026*** | |
| (0.006) | (0.004) | |
| 0.033 | 0.061*** | |
| (0.024) | (0.020) | |
| −0.012 | 0.101 | |
| (0.125) | (0.102) | |
| −0.097 | −0.086 | |
| (0.074) | (0.068) | |
| −0.001 | −0.012*** | |
| (0.006) | (0.004) | |
| −0.040 | 0.104* | |
| (0.060) | (0.054) | |
| −0.003 | −0.126 | |
| (0.242) | (0.233) | |
| 0.026 | −0.129 | |
| (0.160) | (0.114) | |
| −0.052* | 0.010 | |
| (0.030) | (0.025) | |
| −0.003 | 0.009 | |
| (0.011) | (0.010) | |
| −0.597 | −0.703 | |
| (0.539) | (0.429) | |
| 8,822 | 9,218 | |
| Yes | Yes | |
| Yes | Yes | |
| 0.070 | 0.073 |
Note(s): This table presents the placebo test results. We advance the policy implementation year by two years (to 2013) and redefine the Post variable for the analysis. Standard errors are reported in parentheses; ***, **, and * indicate statistical significance at the 1%, 5%, and 10% levels, respectively
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.